An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
cbdMD, Inc. announced a conference call on December 16, 2021, at 4:15 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ending September 30, 2021. This session will cover key business developments, and there are options for both domestic and international callers to join. The company is recognized for its extensive line of THC-free CBD products and is committed to transparency in its financial performance and future outlook.
Positive
cbdMD has a comprehensive line of over 130 SKUs of THC-free CBD products.
The conference call will provide insights into the company's financial results and business progress.
Negative
None.
CHARLOTTE, N.C.--(BUSINESS WIRE)--
cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD health & wellness companies, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, December 16, 2021, to discuss the company’s September 30, 2021 fourth quarter and fiscal year end financial results and business progress.
CONFERENCE CALL DETAILS
Thursday, December 16, 2021, 4:15 p.m. Eastern Time
Domestic:
1-888-506-0062
International:
1-973-528-0011
Teleconference Replay dial in – Available through Saturday, January 15, 2022
Domestic:
1-877-481-4010
International:
1-919-882-2331
Replay Passcode:
43904
Webcast Link/Webcast Replay link- available through Friday, December 16, 2022:
cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as our new Full Spectrum products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the "SEC") on December 22, 2020 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
1 THC-free is defined as below the level of detection using validated scientific analytical methods.
